Guest guest Posted May 27, 2009 Report Share Posted May 27, 2009 Wall Street Journal MAY 27, 2009. JENNIFER CORBETT DOOREN FDA Gives Advice on Divulging Risks The Food and Drug Administration issued proposed advertising guidelines for drug and medical-device makers, with suggestions on ways to present risk information to consumers and health-care professionals. The draft guidelines, posted Tuesday on the agency's Web site, aren't binding, but they offer several ways that the industry can avoid running afoul of its rules. The FDA said the omission or minimization of risk information is the most frequent violation cited in dozens of enforcement or warning letters each year. The guidelines suggest a product that requires monthly blood tests to check for liver damage should state that in clear language rather than using language such as the need for " certain monitoring. " *************************************************** Read the rest of the article here: http://online.wsj.com/article/SB124339082067457033.html Not an MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.